矿量子点的联体增强胺兴奋剂用于高级激励子封闭
Xianghua Wang1,2, Lin Zhou1,2, Xudong Zhao1,2
1Special Display and Imaging Technology Innovation Center of Anhui Province, Academy of Opto-Electric Technology, School of Instrument Science and Optoelectronics Engineering, Hefei University of Technology, Hefei 230009, China.
研究人员为充满活力的蓝色显示器开发了改进的矿量子点 (QD). 配体交换和小分子半导体增强了光发光量子产量 (PLQY) 和先进色彩转换层的稳定性.
科学领域:
- 材料科学 材料科学 材料科学
- 光电学是指光电子产品.
- 纳米技术 纳米技术
背景情况:
- 全无机矿量子点 (QDs) 对全彩显示器的纯蓝色辐射具有前景.
- 挑战包括较低的光发光量子产量 (PLQY) 和固态应用中的稳定性问题.
研究的目的:
- 为了提高纯无机矿QDs的性能,以获得纯蓝色的排放.
- 为了改善显示应用的PLQY和光稳定性.
- 使用一种新的复合材料来实现广泛的颜色范围.
主要方法:
- 通过热注射制备CsPbBr3和Cs3NdCl6 QDs.
- 颜色混合的QDs和引入的Nd-doping.
- 使用APTMS修复空缺并增强Nd兴奋剂的联体交换.
- 用BTBT小分子半导体组成复合材料.
主要成果:
- Nd-doped QDs在发射中表现出一个蓝色转移.
- 在APTMS处理中修复了空缺,在466nm时将PLQY提升到94%.
- 使用BTBT的复合膜减少了FRET造成的PLQY损失.
- 实现了124%的NTSC颜色范围和增强的光稳定性.
结论:
- 表面空隙修复和Nd剂显著提高矿QD性能.
- BTBT复合材料的形成改善了固态PLQY和光稳定性.
- 这种方法使高光谱显示器的高效色彩转换层成为可能.
更多相关视频
10:41Enhanced Electron Injection and Exciton Confinement for Pure Blue Quantum-Dot Light-Emitting Diodes by Introducing Partially Oxidized Aluminum Cathode
Published on: May 31, 2018
04:14Facile Synthesis of Colloidal Lead Halide Perovskite Nanoplatelets via Ligand-Assisted Reprecipitation
Published on: October 1, 2019
相关概念视频
Long-term Potentiation
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
